Substance abuse screening in adolescents

DelRosario, Genevieve; Kahle, Laura; Lewis, Kimberly; Lepper, Leigh Tenkku

doi:10.1097/01.jaa.0000525922.99634.0d

Cited by 1 publication

(1 citation statement)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…During an outbreak such as COVID-19, individuals may turn to substances to cope with stress or increased symptoms (Wong et al, 2005) and individuals at CHR may be particularly prone to using this coping mechanism given their higher baseline rates of substance use compared with peers not at CHR. Through telepsychotherapy, clinicians should consider using evidence-based assessment (e.g., DelRosario, Kahle, Lewis, & Lepper, 2017) to monitor and generate discussions about clients’ substance use, in addition to using treatment components that blend MI, CBT, and family work. Clinicians should also probe for polysubstance use and the potential confounding effects of other substances (e.g., alcohol) on mental health symptoms for individuals at CHR (e.g., Auther et al, 2015).…”

Section: Chr Clinical Issues and Treatment Approaches In The Context ...mentioning

confidence: 99%

Telepsychotherapy with youth at clinical high risk for psychosis: Clinical issues and best practices during the COVID-19 pandemic.

Andorko¹,

Chibani²,

Jay³

et al. 2020

Journal of Psychotherapy Integration

View full text Add to dashboard Cite

Early detection and prevention of psychosis has become an international priority. Much of this work has focused on youth presenting with attenuated symptoms of psychosis—those at clinical high risk for psychosis (CHR)—given their elevated probability of developing the full disorder in subsequent years. Individuals at CHR may be prone to exacerbated psychological distress during the coronavirus 2019 (COVID-19) pandemic and its subsequent physical isolation measures, as a result of heightened stress sensitivity and comorbid mental health problems. Telepsychotherapy holds promise for reaching this population, especially during the current COVID-19 outbreak. However, there are limited evidence-based guidelines or interventions for use of telepsychotherapy with this population. In this article, we review common clinical issues for individuals at CHR and how they might be exacerbated by the COVID-19 pandemic. We then review best practices for treatment and adaptations for telepsychotherapy for individuals at CHR, and highlight real clinical issues that we are currently experiencing in a United States–based specialized CHR clinic as we conduct telepsychotherapy via videoconferencing. We conclude with questions for those in the field to contemplate, as well as potential challenges and benefits in using telepsychotherapy with individuals at CHR and their families.

show abstract

Section: Chr Clinical Issues and Treatment Approaches In The Context ...mentioning

confidence: 99%